Semiconductors
Compare Stocks
5 / 10Stock Comparison
ICHR vs MKSI vs UCTT vs CAMT vs AZTA
Revenue, margins, valuation, and 5-year total return — side by side.
Hardware, Equipment & Parts
Semiconductors
Semiconductors
Medical - Instruments & Supplies
ICHR vs MKSI vs UCTT vs CAMT vs AZTA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Hardware, Equipment & Parts | Semiconductors | Semiconductors | Medical - Instruments & Supplies |
| Market Cap | $2.35B | $19.39B | $3.78B | $7.18B | $1.13B |
| Revenue (TTM) | $959M | $3.93B | $2.07B | $472M | $595M |
| Net Income (TTM) | $-51M | $295M | $-194M | $134M | $-62M |
| Gross Margin | 11.3% | 45.2% | 15.6% | 50.3% | 44.6% |
| Operating Margin | -3.8% | 13.7% | -5.3% | 26.6% | -3.2% |
| Forward P/E | 59.2x | 29.0x | 35.8x | 56.7x | 31.4x |
| Total Debt | $186M | $4.69B | $810M | $207M | $51M |
| Cash & Equiv. | $98M | $675M | $312M | $126M | $280M |
ICHR vs MKSI vs UCTT vs CAMT vs AZTA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Ichor Holdings, Ltd. (ICHR) | 100 | 297.9 | +197.9% |
| MKS Inc. (MKSI) | 100 | 272.3 | +172.3% |
| Ultra Clean Holding… (UCTT) | 100 | 401.1 | +301.1% |
| Camtek Ltd. (CAMT) | 100 | 1529.9 | +1429.9% |
| Azenta, Inc. (AZTA) | 100 | 61.6 | -38.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ICHR vs MKSI vs UCTT vs CAMT vs AZTA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ICHR lags the leaders in this set but could rank higher in a more targeted comparison.
MKSI is the #2 pick in this set and the best alternative if value is your priority.
- Lower P/E (29.0x vs 56.7x)
UCTT ranks third and is worth considering specifically for momentum.
- +326.4% vs AZTA's -6.1%
CAMT carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 1.99, yield 0.6%
- Rev growth 36.1%, EPS growth 50.3%, 3Y rev CAGR 16.8%
- 102.6% 10Y total return vs UCTT's 14.4%
- Lower volatility, beta 1.99, Low D/E 37.7%, current ratio 5.00x
Among these 5 stocks, AZTA doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 36.1% revenue growth vs AZTA's -9.5% | |
| Value | Lower P/E (29.0x vs 56.7x) | |
| Quality / Margins | 28.4% margin vs AZTA's -10.3% | |
| Stability / Safety | Beta 1.99 vs ICHR's 3.93 | |
| Dividends | 0.6% yield, 2-year raise streak, vs MKSI's 0.3%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +326.4% vs AZTA's -6.1% | |
| Efficiency (ROA) | 13.7% ROA vs UCTT's -11.0%, ROIC 13.7% vs 2.6% |
ICHR vs MKSI vs UCTT vs CAMT vs AZTA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ICHR vs MKSI vs UCTT vs CAMT vs AZTA — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CAMT leads in 4 of 6 categories
AZTA leads 1 • ICHR leads 0 • MKSI leads 0 • UCTT leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CAMT leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MKSI is the larger business by revenue, generating $3.9B annually — 8.3x CAMT's $472M. CAMT is the more profitable business, keeping 28.4% of every revenue dollar as net income compared to AZTA's -10.3%. On growth, CAMT holds the edge at +20.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $959M | $3.9B | $2.1B | $472M | $595M |
| EBITDAEarnings before interest/tax | -$11M | $883M | -$52M | $161M | $24M |
| Net IncomeAfter-tax profit | -$51M | $295M | -$194M | $134M | -$62M |
| Free Cash FlowCash after capex | -$17M | $496M | -$44M | $0 | $31M |
| Gross MarginGross profit ÷ Revenue | +11.3% | +45.2% | +15.6% | +50.3% | +44.6% |
| Operating MarginEBIT ÷ Revenue | -3.8% | +13.7% | -5.3% | +26.6% | -3.2% |
| Net MarginNet income ÷ Revenue | -5.3% | +7.5% | -9.4% | +28.4% | -10.3% |
| FCF MarginFCF ÷ Revenue | -1.7% | +12.6% | -2.1% | +26.1% | +5.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.7% | +10.6% | +2.9% | +20.2% | +0.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +46.2% | +18.8% | -2.6% | +21.1% | -17.2% |
Valuation Metrics
AZTA leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 65.8x trailing earnings, MKSI trades at a 19% valuation discount to CAMT's 81.5x P/E. On an enterprise value basis, AZTA's 18.0x EV/EBITDA is more attractive than UCTT's 35.8x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.4B | $19.4B | $3.8B | $7.2B | $1.1B |
| Enterprise ValueMkt cap + debt − cash | $2.4B | $23.4B | $4.3B | $7.3B | $900M |
| Trailing P/EPrice ÷ TTM EPS | -44.01x | 65.82x | -20.79x | 81.49x | -18.93x |
| Forward P/EPrice ÷ next-FY EPS est. | 59.22x | 29.03x | 35.84x | 56.68x | 31.38x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 2.33x | — |
| EV / EBITDAEnterprise value multiple | — | 25.75x | 35.76x | — | 18.02x |
| Price / SalesMarket cap ÷ Revenue | 2.48x | 4.93x | 1.84x | — | 1.90x |
| Price / BookPrice ÷ Book value/share | 3.49x | 7.16x | 4.80x | 17.73x | 0.65x |
| Price / FCFMarket cap ÷ FCF | — | 39.01x | 257.28x | — | 29.45x |
Profitability & Efficiency
CAMT leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CAMT delivers a 21.4% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-25 for UCTT. AZTA carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to MKSI's 1.73x. On the Piotroski fundamental quality scale (0–9), CAMT scores 7/9 vs ICHR's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -7.5% | +10.8% | -25.4% | +21.4% | -3.6% |
| ROA (TTM)Return on assets | -5.2% | +3.4% | -11.0% | +13.7% | -3.0% |
| ROICReturn on invested capital | -3.9% | +6.5% | +2.6% | +13.7% | -0.6% |
| ROCEReturn on capital employed | -4.7% | +7.2% | +2.9% | +14.8% | -0.6% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 5 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.28x | 1.73x | 1.03x | 0.38x | 0.03x |
| Net DebtTotal debt minus cash | $87M | $4.0B | $499M | $81M | -$229M |
| Cash & Equiv.Liquid assets | $98M | $675M | $312M | $126M | $280M |
| Total DebtShort + long-term debt | $186M | $4.7B | $810M | $207M | $51M |
| Interest CoverageEBIT ÷ Interest expense | -5.97x | 2.55x | -5.80x | 4356.62x | — |
Total Returns (Dividends Reinvested)
CAMT leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CAMT five years ago would be worth $63,025 today (with dividends reinvested), compared to $2,630 for AZTA. Over the past 12 months, UCTT leads with a +326.4% total return vs AZTA's -6.1%. The 3-year compound annual growth rate (CAGR) favors CAMT at 94.7% vs AZTA's -18.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +232.0% | +71.0% | +204.3% | +70.7% | -26.3% |
| 1-Year ReturnPast 12 months | +225.2% | +287.5% | +326.4% | +194.5% | -6.1% |
| 3-Year ReturnCumulative with dividends | +137.9% | +228.0% | +194.6% | +638.6% | -46.0% |
| 5-Year ReturnCumulative with dividends | +24.2% | +65.5% | +72.2% | +530.3% | -73.7% |
| 10-Year ReturnCumulative with dividends | +593.7% | +724.4% | +1439.6% | +10263.5% | +185.4% |
| CAGR (3Y)Annualised 3-year return | +33.5% | +48.6% | +43.4% | +94.7% | -18.6% |
Risk & Volatility
Evenly matched — UCTT and CAMT each lead in 1 of 2 comparable metrics.
Risk & Volatility
CAMT is the less volatile stock with a 1.99 beta — it tends to amplify market swings less than ICHR's 3.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UCTT currently trades 98.6% from its 52-week high vs AZTA's 59.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.93x | 2.64x | 3.19x | 1.99x | 2.17x |
| 52-Week HighHighest price in past year | $72.87 | $298.00 | $84.33 | $210.20 | $41.73 |
| 52-Week LowLowest price in past year | $13.12 | $71.49 | $18.52 | $62.88 | $19.87 |
| % of 52W HighCurrent price vs 52-week peak | +93.0% | +96.5% | +98.6% | +93.8% | +59.0% |
| RSI (14)Momentum oscillator 0–100 | 65.5 | 65.6 | 50.8 | 52.5 | 50.3 |
| Avg Volume (50D)Average daily shares traded | 793K | 1.1M | 1.4M | 420K | 871K |
Analyst Outlook
CAMT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ICHR as "Buy", MKSI as "Buy", UCTT as "Buy", CAMT as "Buy", AZTA as "Buy". Consensus price targets imply 81.5% upside for AZTA (target: $45) vs -26.5% for ICHR (target: $50). For income investors, CAMT offers the higher dividend yield at 0.62% vs MKSI's 0.30%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $49.80 | $272.86 | $85.00 | $165.60 | $44.67 |
| # AnalystsCovering analysts | 14 | 29 | 12 | 13 | 12 |
| Dividend YieldAnnual dividend ÷ price | — | +0.3% | — | +0.6% | — |
| Dividend StreakConsecutive years of raises | 1 | 0 | 1 | 2 | 0 |
| Dividend / ShareAnnual DPS | — | $0.87 | — | $1.22 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% | +0.1% | — | 0.0% |
CAMT leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). AZTA leads in 1 (Valuation Metrics). 1 tied.
ICHR vs MKSI vs UCTT vs CAMT vs AZTA: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ICHR or MKSI or UCTT or CAMT or AZTA a better buy right now?
For growth investors, Camtek Ltd.
(CAMT) is the stronger pick with 36. 1% revenue growth year-over-year, versus -9. 5% for Azenta, Inc. (AZTA). MKS Inc. (MKSI) offers the better valuation at 65. 8x trailing P/E (29. 0x forward), making it the more compelling value choice. Analysts rate Ichor Holdings, Ltd. (ICHR) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ICHR or MKSI or UCTT or CAMT or AZTA?
On trailing P/E, MKS Inc.
(MKSI) is the cheapest at 65. 8x versus Camtek Ltd. at 81. 5x. On forward P/E, MKS Inc. is actually cheaper at 29. 0x.
03Which is the better long-term investment — ICHR or MKSI or UCTT or CAMT or AZTA?
Over the past 5 years, Camtek Ltd.
(CAMT) delivered a total return of +530. 3%, compared to -73. 7% for Azenta, Inc. (AZTA). Over 10 years, the gap is even starker: CAMT returned +102. 6% versus AZTA's +185. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ICHR or MKSI or UCTT or CAMT or AZTA?
By beta (market sensitivity over 5 years), Camtek Ltd.
(CAMT) is the lower-risk stock at 1. 99β versus Ichor Holdings, Ltd. 's 3. 93β — meaning ICHR is approximately 97% more volatile than CAMT relative to the S&P 500. On balance sheet safety, Azenta, Inc. (AZTA) carries a lower debt/equity ratio of 3% versus 173% for MKS Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ICHR or MKSI or UCTT or CAMT or AZTA?
By revenue growth (latest reported year), Camtek Ltd.
(CAMT) is pulling ahead at 36. 1% versus -9. 5% for Azenta, Inc. (AZTA). On earnings-per-share growth, the picture is similar: Azenta, Inc. grew EPS 57. 9% year-over-year, compared to -869. 2% for Ultra Clean Holdings, Inc.. Over a 3-year CAGR, CAMT leads at 16. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ICHR or MKSI or UCTT or CAMT or AZTA?
Camtek Ltd.
(CAMT) is the more profitable company, earning 27. 6% net margin versus -10. 0% for Azenta, Inc. — meaning it keeps 27. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CAMT leads at 25. 2% versus -4. 1% for ICHR. At the gross margin level — before operating expenses — CAMT leads at 48. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ICHR or MKSI or UCTT or CAMT or AZTA more undervalued right now?
On forward earnings alone, MKS Inc.
(MKSI) trades at 29. 0x forward P/E versus 59. 2x for Ichor Holdings, Ltd. — 30. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AZTA: 81. 5% to $44. 67.
08Which pays a better dividend — ICHR or MKSI or UCTT or CAMT or AZTA?
In this comparison, CAMT (0.
6% yield), MKSI (0. 3% yield) pay a dividend. ICHR, UCTT, AZTA do not pay a meaningful dividend and should not be held primarily for income.
09Is ICHR or MKSI or UCTT or CAMT or AZTA better for a retirement portfolio?
For long-horizon retirement investors, Ultra Clean Holdings, Inc.
(UCTT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1440% 10Y return). Azenta, Inc. (AZTA) carries a higher beta of 2. 17 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (UCTT: +1440%, AZTA: +185. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ICHR and MKSI and UCTT and CAMT and AZTA?
These companies operate in different sectors (ICHR (Technology) and MKSI (Technology) and UCTT (Technology) and CAMT (Technology) and AZTA (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ICHR is a small-cap quality compounder stock; MKSI is a mid-cap quality compounder stock; UCTT is a small-cap quality compounder stock; CAMT is a small-cap high-growth stock; AZTA is a small-cap quality compounder stock. CAMT pays a dividend while ICHR, MKSI, UCTT, AZTA do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.